• Profile
Close

Patient-reported outcomes from the United States clinical trial for a hybrid cochlear implant

Otology & Neurotology Sep 21, 2017

Kelsall DC, et al. - This study dealt with the scrutiny of the patient-reported outcomes (PROs) in subjects with significant residual low-frequency hearing and severe-to-profound high-frequency sensorineural hearing loss (SNHL) who received the hybrid cochlear implant (CI). Marked PRO benefits were illustrated on the spatial and qualities of hearing scale (SSQ), device use questionnaire (DUQ) after 6 and 12 months of CI use by the patients who received the hybrid CI. Owing to the opportunity to maintain beneficial low-frequency acoustic hearing, patients retained music listening abilities, as determined by the University of Washington Clinical Assessment of Music Perception (UW-CAMP).
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay